China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
China flag China · Delayed Price · Currency is CNY
25.20
+0.54 (2.19%)
Feb 3, 2026, 3:00 PM CST

SHA:600750 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
1,9991,0071,3331,3711,0461,100
Trading Asset Securities
110.2310.0150.021,3731,728980.89
Cash & Short-Term Investments
2,1091,0171,3832,7442,7742,081
Cash Growth
132.27%-26.43%-49.60%-1.07%33.30%27.54%
Accounts Receivable
692.55940.69637.79775.45793.54896.52
Other Receivables
13.6616.2964.8743.2648.0510.98
Receivables
706.21956.99702.66818.71841.6914.04
Inventory
530.53460.97487.86386.9377.99246.74
Prepaid Expenses
----3.884.29
Other Current Assets
70.7552.2753.08104.6467.2429.28
Total Current Assets
3,4162,4882,6274,0544,0643,275
Property, Plant & Equipment
1,7841,7141,6321,5201,2201,022
Long-Term Investments
107.891,7281,597174.94158.76156.58
Goodwill
41.7441.7441.7441.7441.7414.78
Other Intangible Assets
392.08397.29408.87379.07395.55377.81
Long-Term Deferred Tax Assets
78.1869.2961.1544.4544.938.98
Long-Term Deferred Charges
3.324.064.662.322.770.59
Other Long-Term Assets
1,06865.9329.0559.0268.9738.01
Total Assets
6,8916,5086,4016,2765,9984,924
Accounts Payable
652.29162.75197.1236.81205.7245.56
Accrued Expenses
66.41983.21856.31813.14692.73312.14
Current Portion of Leases
1.890.461.251.991.7-
Current Income Taxes Payable
72.5357.5848.0919.7712.6321.59
Current Unearned Revenue
103.28288.48293.44358.66299.95169.04
Other Current Liabilities
1,272278.71305.91247.33103.8353.15
Total Current Liabilities
2,1681,7711,7021,6781,317601.49
Long-Term Leases
1.510.111.051.182.79-
Long-Term Unearned Revenue
100.3290.3349.6167.8573.0450.58
Long-Term Deferred Tax Liabilities
16.9717.8920.1221.5922.7220.21
Other Long-Term Liabilities
156.79156.79----
Total Liabilities
2,4442,0361,7731,7681,415672.27
Common Stock
635629.02629.36629.58630630
Additional Paid-In Capital
469.55383.02469.65427.35407.82435.36
Retained Earnings
2,7782,8562,8272,8783,0082,812
Treasury Stock
-86.95-5.72-16.42-31.5-43.28-
Total Common Equity
3,7963,8633,9103,9044,0033,877
Minority Interest
651.94608.83718.76604.41579.45374.43
Shareholders' Equity
4,4474,4724,6294,5084,5824,251
Total Liabilities & Equity
6,8916,5086,4016,2765,9984,924
Total Debt
3.40.562.33.164.49-
Net Cash (Debt)
2,1061,0171,3812,7412,7692,081
Net Cash Growth
132.35%-26.35%-49.63%-1.02%33.08%27.54%
Net Cash Per Share
3.321.611.924.354.383.29
Filing Date Shares Outstanding
624.48638.04984.26625.4623.7630
Total Common Shares Outstanding
624.48638.04984.26625.4623.7630
Working Capital
1,248716.43924.442,3772,7482,674
Book Value Per Share
6.086.053.976.246.426.15
Tangible Book Value
3,3623,4243,4593,4833,5663,484
Tangible Book Value Per Share
5.385.373.515.575.725.53
Buildings
-1,5571,5151,0831,0591,029
Machinery
-1,1331,030879.7796.66729.06
Construction In Progress
-99.3170.9445.67190.772.33
Source: S&P Global Market Intelligence. Standard template. Financial Sources.